Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-25

Clinical Trial Update: A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and efficacy of gadodiamide for narrowing of the aorto-iliac arteries; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gadodiamide (gadodiamide)

Snippet

Sponsor: GE Healthcare | Conditions: Aorto-iliac Stenosis, Arterial Occlusive Diseases | Phase 3 | Status: COMPLETED